IL166752A0 - Inducible alphaviral/orip based gene expression system - Google Patents

Inducible alphaviral/orip based gene expression system

Info

Publication number
IL166752A0
IL166752A0 IL16675205A IL16675205A IL166752A0 IL 166752 A0 IL166752 A0 IL 166752A0 IL 16675205 A IL16675205 A IL 16675205A IL 16675205 A IL16675205 A IL 16675205A IL 166752 A0 IL166752 A0 IL 166752A0
Authority
IL
Israel
Prior art keywords
alphaviral
inducible
gene expression
expression system
based gene
Prior art date
Application number
IL16675205A
Other languages
English (en)
Original Assignee
Cytos Biotechnology Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag
Publication of IL166752A0 publication Critical patent/IL166752A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16675205A 2002-08-22 2005-02-08 Inducible alphaviral/orip based gene expression system IL166752A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40492802P 2002-08-22 2002-08-22
US43225902P 2002-12-11 2002-12-11
PCT/EP2003/009291 WO2004018506A2 (en) 2002-08-22 2003-08-21 Inducible alphaviral/orip based gene expression system

Publications (1)

Publication Number Publication Date
IL166752A0 true IL166752A0 (en) 2006-01-15

Family

ID=31949876

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16675205A IL166752A0 (en) 2002-08-22 2005-02-08 Inducible alphaviral/orip based gene expression system

Country Status (5)

Country Link
US (1) US20060251620A1 (de)
EP (1) EP1530585A2 (de)
AU (1) AU2003266301A1 (de)
IL (1) IL166752A0 (de)
WO (1) WO2004018506A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103203016A (zh) * 2005-03-18 2013-07-17 赛托斯生物技术公司 猫变应原融合蛋白及其用途
EP1922084A4 (de) * 2005-08-11 2011-01-12 Univ Texas Infektiöse klone des chikungunya-virus und deren verwendung
US7892790B2 (en) 2005-10-28 2011-02-22 Hoffmann-La Roche Inc. Protein expression in rodent cells
WO2008119827A1 (en) * 2007-04-02 2008-10-09 Fit Biotech Oy Transreplicase constructs
US9474800B2 (en) * 2008-05-23 2016-10-25 Fit Biotech Oy Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
EP3243526B1 (de) 2010-07-06 2019-11-27 GlaxoSmithKline Biologicals S.A. Verabreichung von rna zur auslösung von mehreren immunpfaden
PT2591114T (pt) 2010-07-06 2016-08-02 Glaxosmithkline Biologicals Sa Imunização de mamíferos de grande porte com doses baixas de arn
EP2590626B1 (de) 2010-07-06 2015-10-28 GlaxoSmithKline Biologicals SA Liposomen aus lipiden, die einen vorteilhaften pka-wert zur verabreichung von rna besitzen
PL4066857T3 (pl) * 2010-08-31 2023-03-20 Glaxosmithkline Biologicals Sa Pegylowane liposomy do dostarczania rna kodującego immunogen
CA2809863A1 (en) * 2010-08-31 2012-03-08 Novartis Ag Lipids suitable for liposomal delivery of protein-coding rna
CA2814386C (en) 2010-10-11 2019-08-20 Novartis Ag Antigen delivery platforms
CN103764121A (zh) * 2011-07-06 2014-04-30 诺华股份有限公司 用于递送rna分子的具有有用n:p比的脂质体
CA2840989A1 (en) 2011-07-06 2013-01-10 Novartis Ag Immunogenic combination compositions and uses thereof
US11639329B2 (en) 2017-08-16 2023-05-02 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
CN116096702A (zh) 2020-07-16 2023-05-09 爱康泰生治疗公司 用于脂质纳米颗粒的阳离子脂质
EP4448485A2 (de) 2021-12-16 2024-10-23 Acuitas Therapeutics, Inc. Lipide zur verwendung in lipidnanopartikelformulierungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686186A (en) * 1984-09-26 1987-08-11 Wisconsin Alumni Research Foundation Recombinant vector and eukaryotic host transformed thereby
US5091309A (en) * 1986-01-16 1992-02-25 Washington University Sindbis virus vectors
US5217879A (en) * 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5458878A (en) * 1990-01-02 1995-10-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity
AU4737597A (en) * 1996-09-25 1998-04-17 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic togavirus vectors
JP2002509729A (ja) * 1998-03-27 2002-04-02 サイトス バイオテクノロジー アーゲー 誘導性のアルファウイルス遺伝子発現系
DE19848017A1 (de) * 1998-10-17 2000-04-20 Multigene Biotech Gmbh Episomal replizierender Vektor zur Expression eines Transgens in Säugerzellen

Also Published As

Publication number Publication date
EP1530585A2 (de) 2005-05-18
WO2004018506A3 (en) 2004-04-22
AU2003266301A1 (en) 2004-03-11
US20060251620A1 (en) 2006-11-09
WO2004018506A2 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
EP1331373A3 (de) Versorgungssystem eines Reduktionsmittels
GB0405884D0 (en) Modified nucleotides
AU2003247858A8 (en) Improved cannula system
GB0305444D0 (en) Parts list system
AU2003226983A8 (en) Extra-substrate control system
AU2003259025A8 (en) Electrosurgical specimen-collection system
GB0305447D0 (en) Parts list system
AU2003268299A8 (en) General operating system
GB0227952D0 (en) Messaging system
IL166752A0 (en) Inducible alphaviral/orip based gene expression system
GB0203071D0 (en) Control system
GB0203519D0 (en) Control system
GB0224039D0 (en) Control system
GB0206222D0 (en) Control system
AU2002950473A0 (en) Expression system
AU2002951347A0 (en) Genetic silencing
AU2002256091A1 (en) Reinforced catheter system
AU2003269228A1 (en) Propulsion system
GB0325494D0 (en) Expression system
GB2407399B (en) Control system
AU2003201718A1 (en) Propulsion system
AU2003300693A1 (en) Thruster system
GB0230197D0 (en) Messaging system
AU2003272153A8 (en) Control system
GB0327585D0 (en) Inducible nucleic acid expression system